BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 28939589)

  • 1. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.
    Kabat GC; Kim MY; Lee JS; Ho GY; Going SB; Beebe-Dimmer J; Manson JE; Chlebowski RT; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1730-1735. PubMed ID: 28939589
    [No Abstract]   [Full Text] [Related]  

  • 2. The association between metabolic health, obesity phenotype and the risk of breast cancer.
    Park YM; White AJ; Nichols HB; O'Brien KM; Weinberg CR; Sandler DP
    Int J Cancer; 2017 Jun; 140(12):2657-2666. PubMed ID: 28268252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women.
    Liang X; Margolis KL; Hendryx M; Rohan TE; Groessl EJ; Thomson CA; Kroenke CH; Simon MS; Lane D; Stefanick M; Luo J
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):155-161. PubMed ID: 28148595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic syndrome in postmenopausal breast cancer survivors].
    Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
    Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolically Healthy/Unhealthy Overweight/Obesity Associations With Incident Heart Failure in Postmenopausal Women: The Women's Health Initiative.
    Cordola Hsu AR; Xie B; Peterson DV; LaMonte MJ; Garcia L; Eaton CB; Going SB; Phillips LS; Manson JE; Anton-Culver H; Wong ND;
    Circ Heart Fail; 2021 Apr; 14(4):e007297. PubMed ID: 33775111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
    Kabat GC; Kim MY; Stefanick M; Ho GYF; Lane DS; Odegaard AO; Simon MS; Bea JW; Luo J; Wassertheil-Smoller S; Rohan TE
    Int J Cancer; 2018 Aug; 143(3):543-551. PubMed ID: 29488210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
    Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
    Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic phenotypes of obesity: frequency, correlates and change over time in a cohort of postmenopausal women.
    Kabat GC; Wu WY; Bea JW; Chen C; Qi L; Stefanick ML; Chlebowski RT; Lane DS; Wactawski-Wende J; Wassertheil-Smoller S; Rohan TE
    Int J Obes (Lond); 2017 Jan; 41(1):170-177. PubMed ID: 27748744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.
    Gaudet MM; Carter BD; Patel AV; Teras LR; Jacobs EJ; Gapstur SM
    Cancer Causes Control; 2014 Jun; 25(6):737-45. PubMed ID: 24715420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study.
    Eckel N; Li Y; Kuxhaus O; Stefan N; Hu FB; Schulze MB
    Lancet Diabetes Endocrinol; 2018 Sep; 6(9):714-724. PubMed ID: 29859908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the impact of obesity and metabolic phenotype on sickness absence. Results from the ICARIA study.
    Catalina-Romero C; Sanchez Chaparro MA; Valdivielso P; Quevedo-Aguado L; Brotons C; Ruilope LM; Calvo-Bonacho E
    Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):383-389. PubMed ID: 30803866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
    Schmitt EB; Nahas-Neto J; Bueloni-Dias F; Poloni PF; Orsatti CL; Petri Nahas EA
    Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolically defined body size and body shape phenotypes and risk of postmenopausal breast cancer in the European Prospective Investigation into Cancer and Nutrition.
    Mahamat-Saleh Y; Rinaldi S; Kaaks R; Biessy C; Gonzalez-Gil EM; Murphy N; Le Cornet C; Huerta JM; Sieri S; Tjønneland A; Mellemkjaer L; Guevara M; Overvad K; Perez-Cornago A; Tin Tin S; Padroni L; Simeon V; Masala G; May A; Monninkhof E; Christakoudi S; Heath AK; Tsilidis K; Agudo A; Schulze MB; Rothwell J; Cadeau C; Severi S; Weiderpass E; Gunter MJ; Dossus L
    Cancer Med; 2023 Jun; 12(11):12668-12682. PubMed ID: 37096432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience.
    Capasso I; Esposito E; Pentimalli F; Crispo A; Montella M; Grimaldi M; De Marco M; Cavalcanti E; D'Aiuto M; Fucito A; Frasci G; Maurea N; Esposito G; Pedicini T; Vecchione A; D'Aiuto G; Giordano A
    Cancer Biol Ther; 2010 Dec; 10(12):1240-3. PubMed ID: 20935521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of diabetes according to metabolically healthy or unhealthy normal weight or overweight/obesity in postmenopausal women: the Women's Health Initiative.
    Cordola Hsu AR; Ames SL; Xie B; Peterson DV; Garcia L; Going SB; Phillips LS; Manson JE; Anton-Culver H; Wong ND
    Menopause; 2020 Jun; 27(6):640-647. PubMed ID: 32108731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.
    Thomson CA; Thompson PA; Wright-Bea J; Nardi E; Frey GR; Stopeck A
    J Womens Health (Larchmt); 2009 Dec; 18(12):2041-7. PubMed ID: 20044868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
    Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
    J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it.
    Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S
    Menopause; 2010; 17(3):566-70. PubMed ID: 20054286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.